These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
878 related articles for article (PubMed ID: 17321235)
1. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235 [TBL] [Abstract][Full Text] [Related]
2. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Sandha GS; Severin D; Postema E; McEwan A; Stewart K Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202 [TBL] [Abstract][Full Text] [Related]
3. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562 [TBL] [Abstract][Full Text] [Related]
4. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study. McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963 [TBL] [Abstract][Full Text] [Related]
6. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134 [TBL] [Abstract][Full Text] [Related]
7. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. Flamen P; Lerut A; Van Cutsem E; Cambier JP; Maes A; De Wever W; Peeters M; De Leyn P; Van Raemdonck D; Mortelmans L J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1085-92. PubMed ID: 11088030 [TBL] [Abstract][Full Text] [Related]
8. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography. Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925 [TBL] [Abstract][Full Text] [Related]
9. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer. Chang KJ; Soetikno RM; Bastas D; Tu C; Nguyen PT Endoscopy; 2003 Nov; 35(11):962-6. PubMed ID: 14606021 [TBL] [Abstract][Full Text] [Related]
10. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Pech O; May A; Günter E; Gossner L; Ell C Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186 [TBL] [Abstract][Full Text] [Related]
11. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Basu D; Siegel BA; McDonald DJ; Nussenbaum B Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620 [TBL] [Abstract][Full Text] [Related]
13. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET. Sloof GW Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171 [TBL] [Abstract][Full Text] [Related]
14. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339 [TBL] [Abstract][Full Text] [Related]
15. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Choi J; Kim SG; Kim JS; Jung HC; Song IS Surg Endosc; 2010 Jun; 24(6):1380-6. PubMed ID: 20033712 [TBL] [Abstract][Full Text] [Related]
16. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Erasmus JJ; Munden RF Semin Radiat Oncol; 2007 Jan; 17(1):29-37. PubMed ID: 17185195 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer. Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735 [TBL] [Abstract][Full Text] [Related]
20. The evolving role of PET-CT in the management of esophageal cancer. Chuang HH; Macapinlac HA Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):201-9. PubMed ID: 19293768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]